Unlock mRNA Platforms for Next Generation Therapeutics & Vaccines from Concept to Clinical Validation & Commercialization for Patients in Need Across All Disease Indications

The Flagship Meeting of the mRNA Calendar

May - 32384 - mRNA News Headlines

Welcome to the largest gathering for mRNA professionals

With over 800 mRNA drugs now in development and the industry accelerating towards clinical success, the mRNA-Based Therapeutics Summit returns for its 3rd year as the industry’s largest networking opportunity to date, showcasing exclusive new data from the movers and shakers in the field.

Ensure your whole team stays ahead of the curve by joining 300+ key mRNA opinion leaders from Moderna, BioNTech, Sanofi including regulatory insights from the FDA and EMA at the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.

Expect 100+ world-class speakers from large pharma, innovative biotechs, and academia, with 3 days of  jam-packed content with 5 dedicated tracks (discovery, translation, clinical development, chemistry, manufacturing and controls (CMC) and logistics) deep-dive focus and workshop days, C-Level Fireside Discussions and more, enabling you to overcome industry hurdles including optimized dosing, targeted delivery, safety and scalability to achieve regulatory success in infectious and rare diseases, cancer and beyond!


“The meeting is for sure one of the important events to bring scientists from academia and industry together  for exchange and networking in the field of RNA therapeutics”

Heinrich Haas, VP – RNA Formulation & Drug Delivery, BioNTech

Among Our World-Class Speaker Faculty

Michael Wenger

Vice President - Clinical Development

BioNTech SE

Sonia Stoszek

Executive Director & Program Lead – RSV Vaccines


Aleksandra Pastrak


Providence Therapeutics

Peter Marks

Director - Center For Biologics Evaluation & Research

US Food & Drug Administration (FDA)

Alexander Zehnder


Curevac GmbH



Kernal Biologics Inc.

Kathleen Francissen

Global Head of Regulatory PT Cell & Gene Therapies


Frank DeRosa

Chief Technology Officer & Global Head of Research, mRNA Center of Excellence


“Attending the 3rd mRNA-Based Therapeutics Summit provides the opportunity to keep up to date with the latest advances in the rapidly developing field of mRNA-based vaccines and therapeutics, and in a comprehensive manner covering important aspects ranging from early discovery through manufacturing and clinical development”

Daryl Drummond, CSO & Co-Founder, Akagera Medicines

Companies Attending

The Biggest Meeting in the mRNA Calendar




World-Class Speakers


Hours of Dedicated In-Person Networking


Tracks of Content


Pre-Conference Days


Pre-Conference Workshop Day


Interactive Panel Discussions

“This is the most comprehensive conference for mRNA and related approaches in the field”

Nathaniel Wang, CEO & Co-Founder

Lead Partner

Hosting Partners

Expertise Partners

Other Events in the World RNA Series: